Sr Clinical Development Director
GSK, Collegeville, PA, USA
Disclosure: GlaxoSmithKline (Employee)
PhD Kings College, University of London Department of Microbiology
Over twenty years’ experience in Clinical Drug Development at GSK spanning Antibacterial Infectious Disease (mupirocin, augmentin, gemifloxacin, and gepotidacin). Currently Sr Clinical Development Director, for gepotidacin a novel DNA gyrase antibacterial agent under development for GC, and uUTI. I manage a team of three Clinical scientists based at Collegeville, PA USA
